Guillain-Barré Syndrome deaths ‘likely linked’ to COVID vaccine An independent expert group has confirmed the two fatal cases are likely linked to AstraZeneca, but the complexity of the syndrome means uncertainties remain.
Vaccine myocarditis risk reaches 1 in 10,000 for adolescent boys But while the rate of Pfizer-related myocarditis continues to increase in males aged 12–17, research cited by the TGA indicates the risk is still dwarfed by the threat COVID-19 poses to this cohort.
Guillain-Barre Syndrome warning for AstraZeneca The TGA has updated the vaccine’s Product Information regarding the ‘very rare’ possibility of contracting the disorder.
New PBS listing to ease burden of inflammatory bowel disease The listing of the treatment of moderate-to-severe ulcerative colitis is a key step in helping thousands of Australians.
Australian authorities update side effect advice on AstraZeneca vaccine The ATAGI release confirms most over-50s can receive the vaccine, and that the rare blood clotting linked to AstraZeneca can be treated effectively.
Research backs cheaper IBD drug alternative A new study suggests switching patients with inflammatory bowel disease to biosimilar infliximab is safe, effective and could save millions.
Inflammatory syndrome linked to SARS-CoV-2 can affect adults The CDC says the new adult syndrome closely resembles the previously identified paediatric one.
WHO develops preliminary case definition for inflammatory syndrome in children The COVID-19-associated syndrome seems to be its own unique entity.
‘Important’ link between paediatric inflammatory syndromes and COVID-19 Australian researchers have been commissioned to investigate the mystery illness, following the death of at least three children in the US.
‘I thought it was just me’: Registrars and impostor syndrome Feeling like a fraud is common for general practice registrars, but the issue is often shrouded in secrecy.